Jasplakinolide's Inhibition of the Growth of Prostate Carcinoma Cells In Vitro With Disruption of the Actin Cytoskeleton - Concepedia

Concepedia

Publication | Closed Access

Jasplakinolide's Inhibition of the Growth of Prostate Carcinoma Cells In Vitro With Disruption of the Actin Cytoskeleton

155

Citations

0

References

1995

Year

Adrian M. Senderowicz, Gurmeet Kaur, Eugenia Sainz, Carol Laing, Wayne D. Inman, P. Crews, Louis Malspeis, M. R. Grever, Edward A. Sausville, Kimberly L.K. Duncan

JNCI Journal of the National Cancer Institute

Abstract

Jasplakinolide is a potential candidate for further preclinical development and a lead structure for a novel class of therapeutic agents that can disrupt the actin cytoskeleton in mammalian cells.